Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is 49.07% vs 36.89% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is -1.38% vs -15.03% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is 86.58% vs 54.94% in Mar 2025
Compare Balance Sheet Results of Parmax Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
4.45
11.05
-6.60
-59.73%
Share Warrants & Outstandings
Total Reserve
-10.60
46.77
-57.37
-122.66%
Shareholder's Funds
-6.15
57.82
-63.97
-110.64%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
12.06
6.39
5.67
88.73%
Secured Loans
7.93
3.07
4.86
158.31%
Unsecured Loans
4.13
3.32
0.81
24.40%
Deferred Tax Assets / Liabilities
-1.88
-0.22
-1.66
-754.55%
Other Long Term Liabilities
0.00
0.09
-0.09
-100.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.00
0.00
0.00%
Total Non-Current Liabilities
9.64
1.44
8.20
569.44%
Current Liabilities
Trade Payables
14.34
21.26
-6.92
-32.55%
Other Current Liabilities
7.33
3.34
3.99
119.46%
Short Term Borrowings
0.54
10.53
-9.99
-94.87%
Short Term Provisions
0.47
0.00
0.47
0.00%
Total Current Liabilities
22.68
35.13
-12.45
-35.44%
Total Liabilities
26.17
94.39
-68.22
-72.27%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
18.59
29.25
-10.66
-36.44%
Less: Accumulated Depreciation
10.73
11.17
-0.44
-3.94%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
7.86
18.08
-10.22
-56.53%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
1.71
-1.71
-100.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.40
12.18
-11.78
-96.72%
Long Term Loans & Advances
1.23
0.00
1.23
0.00%
Other Non Current Assets
0.00
0.00
0.00
0.00%
Total Non-Current Assets
9.49
31.97
-22.48
-70.32%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
7.85
15.28
-7.43
-48.63%
Sundry Debtors
3.16
28.79
-25.63
-89.02%
Cash and Bank
0.65
0.34
0.31
91.18%
Other Current Assets
0.00
9.31
-9.31
-100.00%
Short Term Loans and Advances
5.02
8.70
-3.68
-42.30%
Total Current Assets
16.68
62.42
-45.74
-73.28%
Net Current Assets (Including Current Investments)
-6.00
27.29
-33.29
-121.99%
Total Current Assets Excluding Current Investments
16.68
62.42
-45.74
-73.28%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
26.17
94.39
-68.22
-72.27%
Contingent Liabilities
0.00
1.78
-1.78
-100.00%
Total Debt
11.52
7.26
4.26
58.68%
Book Value per share (adjusted)
-13.81
52.33
-66.14
-126.39%
Annual - Borrowings
Borrowings 12.06 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 49.07% vs 36.89% in Mar 2025
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 7.86 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -1.38% vs -15.03% in Mar 2025
Annual - Investments
Investments 0.40 Cr
in Mar 2026Figures in Cr
No Investments in the last few periods;
Annual - Current Assets
Current Assets 16.68 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 86.58% vs 54.94% in Mar 2025
